{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T20:42:41Z","timestamp":1789764161257,"version":"4.0.1"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Chinese National Basic Research Program","award":["2011CB504100"],"award-info":[{"award-number":["2011CB504100"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["31000476"],"award-info":[{"award-number":["31000476"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.expneurol.2013.06.002","type":"journal-article","created":{"date-parts":[[2013,6,10]],"date-time":"2013-06-10T15:17:56Z","timestamp":1370877476000},"page":"148-156","source":"Crossref","is-referenced-by-count":88,"special_numbering":"C","title":["AAV2-mediated striatum delivery of human CDNF prevents the deterioration of midbrain dopamine neurons in a 6-hydroxydopamine induced parkinsonian rat model"],"prefix":"10.1016","volume":"248","author":[{"given":"Xinmiao","family":"Ren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanzheng","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2013.06.002_bb0005","first-page":"31","article-title":"Single administration of GDNF into the striatum induced protection and repair of the nigrostriatal dopaminergic system in the intrastriatal 6-hydroxydopamine injection model of hemiparkinsonism","volume":"17","author":"Aoi","year":"2001","journal-title":"Restor. Neurol. Neurosci."},{"key":"10.1016\/j.expneurol.2013.06.002_bb0010","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/brb3.117","article-title":"Gene therapy with AAV2-CDNF provides functional benefits in a rat model of Parkinson's disease","volume":"3","author":"Back","year":"2013","journal-title":"Brain Behav."},{"key":"10.1016\/j.expneurol.2013.06.002_bb0015","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.ymthe.2006.05.005","article-title":"Long-term clinical improvement in MPTP-lesioned primates after gene therapy with AAV-hAADC","volume":"14","author":"Bankiewicz","year":"2006","journal-title":"Mol. Ther."},{"key":"10.1016\/j.expneurol.2013.06.002_bb0020","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.nbd.2005.06.015","article-title":"Functional reinnervation from remaining DA terminals induced by GDNF lentivirus in a rat model of early Parkinson's disease","volume":"21","author":"Brizard","year":"2006","journal-title":"Neurobiol. Dis."},{"issue":"Suppl. 2","key":"10.1016\/j.expneurol.2013.06.002_bb0025","first-page":"II11","article-title":"Morphological and functional imaging studies on the diagnosis and progression of Parkinson's disease","volume":"247","author":"Brooks","year":"2000","journal-title":"J. Neurol."},{"key":"10.1016\/j.expneurol.2013.06.002_bb0030","first-page":"1186","article-title":"Cocaine congeners as PET imaging probes for dopamine terminals","volume":"37","author":"Brownell","year":"1996","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.expneurol.2013.06.002_bb0035","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0361-9230(99)00136-7","article-title":"Alpha-synuclein and Parkinson's disease","volume":"50","author":"Burke","year":"1999","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.expneurol.2013.06.002_bb0040","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1038\/sj.gt.3302116","article-title":"Gene therapy progress and prospects: Parkinson's disease","volume":"10","author":"Burton","year":"2003","journal-title":"Gene Ther."},{"key":"10.1016\/j.expneurol.2013.06.002_bb0045","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1046\/j.1460-9568.2002.01938.x","article-title":"Neuroinflammation of the nigrostriatal pathway during progressive 6-OHDA dopamine degeneration in rats monitored by immunohistochemistry and PET imaging","volume":"15","author":"Cicchetti","year":"2002","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.expneurol.2013.06.002_bb0050","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","article-title":"Parkinson's disease: mechanisms and models","volume":"39","author":"Dauer","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.expneurol.2013.06.002_bb0055","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/nrg1831","article-title":"Genetics of Parkinson disease: paradigm shifts and future prospects","volume":"7","author":"Farrer","year":"2006","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.expneurol.2013.06.002_bb0060","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1006\/exnr.2002.8006","article-title":"Aberrant sprouting and downregulation of tyrosine hydroxylase in lesioned nigrostriatal dopamine neurons induced by long-lasting overexpression of glial cell line derived neurotrophic factor in the striatum by lentiviral gene transfer","volume":"177","author":"Georgievska","year":"2002","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2013.06.002_bb0065","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jneumeth.2011.01.023","article-title":"Ex vivo identification of protein\u2013protein interactions involving the dopamine transporter","volume":"196","author":"Hadlock","year":"2011","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.expneurol.2013.06.002_bb0070","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.expneurol.2011.04.015","article-title":"Commentary on chronic infusion of CDNF prevents 6-OHDA-induced deficits in a rat model of Parkinson's disease. Merja H. Voutilainen et al","volume":"230","author":"Hoffer","year":"2011","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2013.06.002_bb0075","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/ana.20737","article-title":"Randomized controlled trial of intraputamenal glial cell line-derived neurotrophic factor infusion in Parkinson disease","volume":"59","author":"Lang","year":"2006","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2013.06.002_bb0080","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/1531-8249(200004)47:4<493::AID-ANA13>3.0.CO;2-4","article-title":"In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson's disease","volume":"47","author":"Lee","year":"2000","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2013.06.002_bb0085","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/dneu.20760","article-title":"Novel CDNF\/MANF family of neurotrophic factors","volume":"70","author":"Lindholm","year":"2010","journal-title":"Dev. Neurobiol."},{"key":"10.1016\/j.expneurol.2013.06.002_bb0090","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/nature05957","article-title":"Novel neurotrophic factor CDNF protects and rescues midbrain dopamine neurons in vivo","volume":"448","author":"Lindholm","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.expneurol.2013.06.002_bb0095","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.nucmedbio.2009.06.005","article-title":"Evaluation of nigrostriatal damage and its change over weeks in a rat model of Parkinson's disease: small animal positron emission tomography studies with [(11)C]beta-CFT","volume":"36","author":"Liu","year":"2009","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.expneurol.2013.06.002_bb0100","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1089\/154732804773099335","article-title":"Recombinant adeno-associated virus as delivery vector for gene therapy\u2014a review","volume":"13","author":"Lu","year":"2004","journal-title":"Stem Cells Dev."},{"key":"10.1016\/j.expneurol.2013.06.002_bb0105","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/S1474-4422(08)70065-6","article-title":"Safety and tolerability of intraputaminal delivery of CERE-120 (adeno-associated virus serotype 2-neurturin) to patients with idiopathic Parkinson's disease: an open-label, phase I trial","volume":"7","author":"Marks","year":"2008","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.expneurol.2013.06.002_bb0110","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1021\/jm00059a010","article-title":"Substituted 3-phenyltropane analogs of cocaine: synthesis, inhibition of binding at cocaine recognition sites, and positron emission tomography imaging","volume":"36","author":"Meltzer","year":"1993","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.expneurol.2013.06.002_bb0115","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/978-3-7091-0643-3_13","article-title":"Gene therapy for Parkinson's disease","author":"Mochizuki","year":"2003","journal-title":"J. Neural Transm. Suppl."},{"key":"10.1016\/j.expneurol.2013.06.002_bb0120","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/nrd3366","article-title":"Potential therapeutic uses of BDNF in neurological and psychiatric disorders","volume":"10","author":"Nagahara","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.expneurol.2013.06.002_bb0125","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1523\/JNEUROSCI.16-02-00436.1996","article-title":"The dopamine transporter is localized to dendritic and axonal plasma membranes of nigrostriatal dopaminergic neurons","volume":"16","author":"Nirenberg","year":"1996","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2013.06.002_bb0130","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1002\/1531-8249(200006)47:6<804::AID-ANA14>3.0.CO;2-F","article-title":"Progression in Parkinson's disease: a positron emission tomography study with a dopamine transporter ligand [18F]CFT","volume":"47","author":"Nurmi","year":"2000","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2013.06.002_bb0135","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0006-8993(02)02934-7","article-title":"Dopaminergic neuroprotection and regeneration by neurturin assessed by using behavioral, biochemical and histochemical measurements in a model of progressive Parkinson's disease","volume":"947","author":"Oiwa","year":"2002","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2013.06.002_bb0140","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/protein\/gzn080","article-title":"The structure of the conserved neurotrophic factors MANF and CDNF explains why they are bifunctional","volume":"22","author":"Parkash","year":"2009","journal-title":"Protein Eng. Des. Sel."},{"key":"10.1016\/j.expneurol.2013.06.002_bb0145","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.nurt.2008.02.003","article-title":"Treatment of Parkinson's disease with trophic factors","volume":"5","author":"Peterson","year":"2008","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.expneurol.2013.06.002_bb0150","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1385\/JMN:20:2:173","article-title":"MANF: a new mesencephalic, astrocyte-derived neurotrophic factor with selectivity for dopaminergic neurons","volume":"20","author":"Petrova","year":"2003","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.expneurol.2013.06.002_bb0165","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1046\/j.1460-9568.1999.00566.x","article-title":"Protection and regeneration of nigral dopaminergic neurons by neurturin or GDNF in a partial lesion model of Parkinson's disease after administration into the striatum or the lateral ventricle","volume":"11","author":"Rosenblad","year":"1999","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.expneurol.2013.06.002_bb0160","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1006\/exnr.1999.7296","article-title":"Sequential administration of GDNF into the substantia nigra and striatum promotes dopamine neuron survival and axonal sprouting but not striatal reinnervation or functional recovery in the partial 6-OHDA lesion model","volume":"161","author":"Rosenblad","year":"2000","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2013.06.002_bb0155","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1046\/j.1460-9568.2003.02456.x","article-title":"Long-term striatal overexpression of GDNF selectively downregulates tyrosine hydroxylase in the intact nigrostriatal dopamine system","volume":"17","author":"Rosenblad","year":"2003","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.expneurol.2013.06.002_bb0170","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1111\/j.1471-4159.2005.03139.x","article-title":"Long-term glial cell line-derived neurotrophic factor overexpression in the intact nigrostriatal system in rats leads to a decrease of dopamine and increase of tetrahydrobiopterin production","volume":"93","author":"Sajadi","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2013.06.002_bb0175","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/0306-4522(94)90605-X","article-title":"Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: a combined retrograde tracing and immunocytochemical study in the rat","volume":"59","author":"Sauer","year":"1994","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2013.06.002_bb0180","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s00441-004-0938-y","article-title":"Classic toxin-induced animal models of Parkinson's disease: 6-OHDA and MPTP","volume":"318","author":"Schober","year":"2004","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.expneurol.2013.06.002_bb0185","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1590\/S1516-31802006000300014","article-title":"Parkinson's disease and dopamine transporter neuroimaging: a critical review","volume":"124","author":"Shih","year":"2006","journal-title":"Sao Paulo Med. J."},{"key":"10.1016\/j.expneurol.2013.06.002_bb0190","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1002\/ana.21204","article-title":"Dopamine transporter relation to dopamine turnover in Parkinson's disease: a positron emission tomography study","volume":"62","author":"Sossi","year":"2007","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2013.06.002_bb0195","doi-asserted-by":"crossref","first-page":"813","DOI":"10.2967\/jnumed.111.101436","article-title":"In vivo dopamine transporter imaging in a unilateral 6-hydroxydopamine rat model of Parkinson disease using 11C-methylphenidate PET","volume":"53","author":"Sossi","year":"2012","journal-title":"J. Nucl. Med."},{"issue":"Suppl. 3","key":"10.1016\/j.expneurol.2013.06.002_bb0200","doi-asserted-by":"crossref","first-page":"S421","DOI":"10.1016\/S1353-8020(08)70041-5","article-title":"Positron emission tomography in premotor Parkinson's disease","volume":"13","author":"Stoessl","year":"2007","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.expneurol.2013.06.002_bb0210","doi-asserted-by":"crossref","first-page":"9651","DOI":"10.1523\/JNEUROSCI.0833-09.2009","article-title":"Mesencephalic astrocyte-derived neurotrophic factor is neurorestorative in rat model of Parkinson's disease","volume":"29","author":"Voutilainen","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2013.06.002_bb0205","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.expneurol.2010.12.013","article-title":"Chronic infusion of CDNF prevents 6-OHDA-induced deficits in a rat model of Parkinson's disease","volume":"228","author":"Voutilainen","year":"2011","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2013.06.002_bb0215","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1089\/hum.2006.128","article-title":"Hybrid adeno-associated virus bearing nonhomologous inverted terminal repeats enhances dual-vector reconstruction of minigenes in vivo","volume":"18","author":"Yan","year":"2007","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.expneurol.2013.06.002_bb0220","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jneumeth.2004.10.004","article-title":"Histological, behavioural and neurochemical evaluation of medial forebrain bundle and striatal 6-OHDA lesions as rat models of Parkinson's disease","volume":"144","author":"Yuan","year":"2005","journal-title":"J. Neurosci. Methods"}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001448861300174X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001448861300174X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,12]],"date-time":"2024-05-12T04:29:24Z","timestamp":1715488164000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001448861300174X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":44,"alternative-id":["S001448861300174X"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2013.06.002","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]}}}